The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
GPR139激动剂TAK-041可引起精神分裂症患者脑血流量和奖赏系统功能的时间依赖性改变：一项随机安慰剂对照试验
期刊:Psychopharmacology
影响因子:3.3
doi:10.1007/s00213-025-06884-x
Hawkins, Peter C T; Schwarz, Adam J; Stone, James M; Pepper, Fiona; Gilleen, James; Gijsen, Sam; Mazibuko, Ndabezinhle; Arkilo, Dimitrios; Yin, Wei; Wu, Jingtao; Khudyakov, Polyna; Behrje, Rhett; Rosen, Laura; Posener, Joel; Mehta, Mitul A; Laurenza, Antonio
